PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Sanin, V.* ; Schmieder, R.* ; Ates, S.* ; Schlieben, L.D. ; Wiehler, J.* ; Sun, R.* ; Decker, M.* ; Sander, M.* ; Holdenrieder, S.* ; Kohlmayer, F.* ; Friedmann, A.* ; Mall, V.* ; Feiler, T.* ; Dressler, A.* ; Strom, T.M.* ; Prokisch, H. ; Meitinger, T.* ; von Scheidt, M.* ; Koenig, W.* ; Leipold, G.* ; Schunkert, H.*

Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: Design of the VRONI study.

Med. Genet. 34, 41-51 (2022)
Publ. Version/Full Text DOI
Open Access Hybrid
Creative Commons Lizenzvertrag
Familial hypercholesterolemia (FH) is the most frequent monogenic disorder (prevalence 1:250) in the general population. Early diagnosis during childhood enables pre-emptive treatment, thus reducing the risk of severe atherosclerotic manifestations later in life. Nonetheless, FH screening programs are scarce. VRONI offers all children aged 5-14 years in Bavaria a FH screening in the context of regular pediatric visits. LDL-cholesterol (LDL-C) is measured centrally, followed by genetic analysis for FH if exceeding the age-specific 95th percentile (130 mg/dl, 3.34 mmol/l). Children with FH pathogenic variants are treated by specialized pediatricians and offered a FH-focused training course by a qualified training center. Reverse cascade screening is recommended for all first-degree relatives. VRONI aims to prove the feasibility of a population-based FH screening in children and to lay the foundation for a nationwide screening program.
Impact Factor
Scopus SNIP
Altmetric
0.836
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Digimed Bayern ; Vroni ; Familial Hypercholesterolemia ; Hyperlipidemia ; Atherosclerosis ; Screening; Goal Attainment; Care; Identification; Association; Guidelines; Guidance
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0936-5931
e-ISSN 1863-5490
Journal Medizinische Genetik
Quellenangaben Volume: 34, Issue: 1, Pages: 41-51 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Genthiner Strasse 13, D-10785 Berlin, Germany
Reviewing status Peer reviewed
Institute(s) Institute of Neurogenomics (ING)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-503292-001
Grants Bavarian State Ministry of Health and Care
DOI 10.1515/medgen-2022-2115
WOS ID 000791502400006
WOS ID WOS:000791502400006
Scopus ID 85130603810
Erfassungsdatum 2022-06-29
[➜Report correction]